erythromycin has been researched along with Gastritis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campa, M; Favini, P; Malizia, T; Marchetti, F; Pizzarelli, G; Senesi, S; Tejada, M | 1 |
| Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
| Burette, A; Glupczynski, Y | 1 |
| Dent, J; McNulty, CA; Wise, R | 1 |
| Crump, B; Davis, M; Donovan, IA; Gearty, JC; Lister, DM; McNulty, CA; Melikian, V; Wise, R | 1 |
| McNulty, CA | 1 |
| Cervený, R; Gebhart, A | 1 |
1 trial(s) available for erythromycin and Gastritis
| Article | Year |
|---|---|
Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
Topics: Adult; Aged; Bismuth; Campylobacter; Campylobacter Infections; Clinical Trials as Topic; Erythromycin; Erythromycin Ethylsuccinate; Female; Gastric Mucosa; Gastritis; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Salicylates; Salicylic Acid | 1986 |
6 other study(ies) available for erythromycin and Gastritis
| Article | Year |
|---|---|
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Synergism; Erythromycin; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Roxithromycin | 1998 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment.
Topics: Adult; Azithromycin; Campylobacter Infections; Drug Resistance, Microbial; Erythromycin; Gastritis; Humans | 1990 |
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cefoxitin; Ciprofloxacin; Erythromycin; Gastritis; Gentamicins; Humans; Metronidazole; Nalidixic Acid; Organometallic Compounds; Penicillin Resistance; Penicillins; Quinolines; Sulfamethoxazole; Tartrates; Trimethoprim | 1985 |
The treatment of Campylobacter-associated gastritis.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Erythromycin; Erythromycin Ethylsuccinate; Gastritis; Humans; Organometallic Compounds; Salicylates | 1987 |
[Contribution to the problem of staphylococcal enterocolitis].
Topics: Adult; Anti-Bacterial Agents; Chloramphenicol; Cholecystectomy; Enterocolitis, Pseudomembranous; Erythromycin; Female; Gastritis; Humans; Kanamycin; Male; Middle Aged; Penicillins; Postoperative Complications; Staphylococcal Infections; Streptomycin; Tetracycline | 1966 |